Former Health Minister Urges Taiwan, Charities To Prod Orphan Drugs
This article was originally published in PharmAsia News
A former Taiwan health official says the government and charities should take a role in encouraging research and development on orphan drugs in the country. Chen Chien-jen, an epidemiologist at Academia Sinica and former Department of Health minister, said only a few drug makers are willing to work on drugs for rare diseases and the private sector needs more investment to spur it to act. He said the government and charities could do more to promote investment in R&D for such drugs. (Click here for more
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.